This conference has been POSTPONED.
Actual Dates: Mar 19 - 21, 2020
Revised Dates: July 09 -11, 2020
NYU Langone Seminar In Advanced Rheumatology is organized by New York University (NYU) School of Medicine and will be held from Jul 09 - 11, 2020 at NYU Langone Health, New York City, New York, United States of America.
Target Audience:Rheumatologists and trainees in the rheumatic diseases, orthopedists, internists, other physicians with a special interest in rheumatology, as well as, nursing and allied health professionals.
Credit Designation Statement:
The NYU Grossman School of Medicine designates this live activity for a maximum of 21.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
3/19: 6.25 AMA PRA Category 1 Credits™
3/20: 7.5 AMA PRA Category 1 Credits™
3/21: 3.5 AMA PRA Category 1 Credits™
3/19: 1.0 AMA PRA Category 1 Credits™
3/20: 1.0 AMA PRA Category 1 Credits™
Meet-the-Professor Lunchtime Workshops:
3/19: 1.25 AMA PRA Category 1 Credits™
3/20: 1.25 AMA PRA Category 1 Credits™
Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The annual NYU Langone Seminar in Advanced Rheumatology is one of the longest running rheumatology educational courses in the nation. The two and one-half day conference reviews and addresses those areas where current knowledge in the treatment of rheumatic diseases is available. The course focuses on the state-of-the-art in rheumatology at the intersection of new clinical knowledge and its translation into practice. Rheumatology is a fast-moving field in which new discoveries are continually being made and new treatment modalities developed. Because the basic and clinical scientific underpinnings of rheumatologic practice frequently and directly come to impact therapy, this course will also explore those areas of leading-edge science that are likely to prove important to the treatment and management of patients with rheumatic disease. Lectures and year-in-review updates will provide participants with the most recent information in arthritis, lupus, and the full-range of rheumatologic conditions. In addition, panel discussions and optional meet-the-professor sessions will provide small group sessions for participants to raise questions and participate in dialogue with the course instructors and clinical experts.
After participating in this activity, clinicians should be able to:
• Recognize the clinical benefits, and manage risks of protein based biologic therapies for treatment of rheumatoid arthritis, psoriasis, and psoriatic arthritis, develop strategies to determine when to introduce small-molecule signal transduction inhibitors into treatment, and recognize the presence of co-morbidities associated with rheumatic diseases and account for these in treatment
• Evaluate new and future treatment approaches for lupus management and consider the roles of specific immune cells, genetics and cytokines in the pathogenesis of lupus, and the potential to exploit these factors as therapeutic targets
• Recognize the signs and symptoms of primary vasculitis of the CNS and develop strategies to both diagnose and initiate treatment
|Contact No. :||212.263.5295|
|Registration Type||Last Date||Price|
|Full Course - Regular Fee||07 Jul,2020||USD 579.00|
|Reduced Course - Regular Fee||07 Jul,2020||USD 379.00|
|NYU Langone Department of Rheumatology Faculty and Staff - Regular Fee||07 Jul,2020||USD 149.00|